Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD421 for Established Post-operative Nausea and Vomiting
NCT02449291Phase 3Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Sep 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of amisulpride in postoperative nausea and vomiting (PONV), sponsored by Acacia Pharma Group Plc. Started Sep 2015; status: completed.
02
Drugs
amisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02449291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449291.